Thermo Fisher’s (TMO) $11.5B deal for QIAGEN (QGEN) was the top deal in March 2020 and came at a 23% premium after long speculation of a pending deal, and valuation multiple of near 20X EBITDA and 7.15X EV/Sales. QGEN is in the diagnostics space help...